FEBRUARY 13, 2012

SUNA 2008 - Efficacy and Safety of Silodosin for the Treatment of Signs and Symptoms of BPH: Pooled Results of Two Randomized, Placebo-Controlled Studies and Results of a 9-Month Open-Label Extension Study - Highlight

E-mail Print

PHILADELPHIA, PA, USA (UroToday.com) - Silodosin is an alpha blocker which was recently approved by the FDA for men with BPH.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |